Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 196 entries
View as:

CLEAC (Comparison of Late Versus Early Antiretroviral Therapy in HIV-infected Children)

Phase: N/A Priority: Normal
NCT ID: NCT02674867 Org: User:
Start: 06/30/16 End: 06/30/19 Due: 06/30/20

Qualification of Point-of-Care Assays for Management of HCV Patients

Phase: N/A Priority: Normal
NCT ID: NCT02335320 Org: User:
Start: 03/31/15 End: 03/31/16 Due: 03/31/17

Evaluation of Third-line cART Regimen in Cambodia (3DICAM)

Phase: N/A Priority: Normal
NCT ID: NCT03602690 Org: User:
Start: 10/04/18 End: 04/11/22 Due: 04/11/23

Cross Sectional Survey on the Burden, Impacts and Causes of Hepatitis C Virus (HCV) Outbreak in South West Region in Burkina Faso

Phase: N/A Priority: Normal
NCT ID: NCT04136405 Org: User:
Start: 07/14/20 End: 08/31/21 Due: 08/31/22

Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

Phase: N/A Priority: Normal
NCT ID: NCT00424814 Org: User:
Start: 03/31/07 End: 11/30/12 Due: 11/30/13

Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT06255626 Org: User:
Start: 05/27/24 End: 09/30/25 Due: 09/30/26

Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)

Phase: N/A Priority: Normal
NCT ID: NCT03459157 Org: User:
Start: 11/20/17 End: 06/30/21 Due: 06/30/22

Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT03941210 Org: User:
Start: 03/01/18 End: 03/01/20 Due: 03/01/21

Primary Infection Cohort

Phase: N/A Priority: Normal
NCT ID: NCT03148964 Org: User:
Start: 10/31/96 End: 09/30/25 Due: 09/30/26

Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection

Phase: N/A Priority: Normal
NCT ID: NCT01944527 Org: User:
Start: 10/31/13 End: 06/30/17 Due: 06/30/18

Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis Virus

Phase: N/A Priority: Normal
NCT ID: NCT06674837 Org: User:
Start: 06/01/25 End: 01/31/28 Due: 01/31/29

ANRS 12372 MODERATO Study

Phase: N/A Priority: Normal
NCT ID: NCT04022967 Org: User:
Start: 09/21/20 End: 02/05/25 Due: 02/05/26

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.

Phase: N/A Priority: Normal
NCT ID: NCT06273943 Org: User:
Start: 04/01/24 End: 10/30/26 Due: 10/30/27

Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients

Phase: N/A Priority: Normal
NCT ID: NCT02093754 Org: User:
Start: 05/31/14 End: 03/31/16 Due: 03/31/17

Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT01605890 Org: User:
Start: 07/31/12 End: 12/31/15 Due: 12/31/16

Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT02323308 Org: User:
Start: 12/31/10 End: 06/30/14 Due: 06/30/15

Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study

Phase: N/A Priority: Normal
NCT ID: NCT02592174 Org: User:
Start: 01/26/16 End: 10/27/17 Due: 10/27/18

Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon

Phase: N/A Priority: Normal
NCT ID: NCT00658346 Org: User:
Start: 06/30/10 End: 09/30/16 Due: 09/30/17

Cohort of HIV-infected Children

Phase: N/A Priority: Normal
NCT ID: NCT03235258 Org: User:
Start: 07/31/04 End: 06/30/20 Due: 06/30/21

Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT05409261 Org: User:
Start: 06/02/22 End: 03/31/25 Due: 03/31/26

Prevention of HIV in "Île-de-France"

Phase: N/A Priority: Normal
NCT ID: NCT03113123 Org: User:
Start: 05/03/17 End: 10/31/24 Due: 10/31/25

Health and Migration Trajectories of Housekeepers in Bamako

Phase: N/A Priority: Normal
NCT ID: NCT05472051 Org: User:
Start: 02/28/22 End: 06/22/23 Due: 06/22/24

Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in Cambodia

Phase: N/A Priority: Normal
NCT ID: NCT03992313 Org: User:
Start: 04/21/22 End: 09/23/23 Due: 09/23/24

Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis

Phase: N/A Priority: Normal
NCT ID: NCT00116454 Org: User:
Start: 07/31/05 End: 08/31/13 Due: 08/31/14

4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients

Phase: N/A Priority: Normal
NCT ID: NCT02157311 Org: User:
Start: 07/31/14 End: 01/31/16 Due: 01/31/17